Literature DB >> 18520538

Biliary malignancy: value of arterial, pancreatic, and hepatic phase imaging with multidetector-row computed tomography.

Young Hun Choi1, Jeong Min Lee, Jae Young Lee, Chang Jin Han, Jin Young Choi, Joon Koo Han, Byung Ihn Choi.   

Abstract

OBJECTIVE: To assess the diagnostic value of arterial, pancreatic, and hepatic phase imaging with multidetector-row computed tomography of a bile duct malignancy.
METHODS: Our institutional review board approved this retrospective study and waived the requirement for informed consent. Forty-two patients with surgically proven hilar or extrahepatic cholangiocarcinoma, who underwent preoperative imaging with triple-phasic multidetector-row computed tomography, were included in this study. Images obtained during each phase were reviewed by 2 independent observers who assessed the tumor conspicuity and the biliary extent of the tumor and vascular invasion by the tumor. For quantitative analysis, another radiologist measured the tumor attenuation, the normal liver parenchyma, the aorta, and the main portal vein on each phase image.
RESULTS: The degree of tumor conspicuity was higher in the pancreatic and hepatic phases than in the arterial phase (P < 0.01); however, there was no statistical difference in tumor conspicuity between the pancreatic and hepatic phases (P > 0.05). The mean tumor attenuation was greater in the hepatic phase at 114.2 +/- 24.6 Hounsfield units versus 72.9 +/- 18.3 Hounsfield units in the arterial phase (P < 0.001). The images obtained in the hepatic phases were significantly superior to those obtained in the arterial phase for predicting the tumor involvement into the secondary biliary confluence (P < 0.05). In predicting for the vascular involvement by the tumors, there was no significant difference among the 3 enhancement phases (P > 0.05).
CONCLUSIONS: Routine acquisition of arterial phase images is not necessary for successful detection and evaluation of the extent of hilar or extrahepatic bile duct carcinoma.

Entities:  

Mesh:

Year:  2008        PMID: 18520538     DOI: 10.1097/RCT.0b013e318126c134

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  5 in total

1.  Prognostic significance of contrast-enhanced CT attenuation value in extrahepatic cholangiocarcinoma.

Authors:  Yoshiki Asayama; Akihiro Nishie; Kousei Ishigami; Yasuhiro Ushijima; Yukihisa Takayama; Daisuke Okamoto; Nobuhiro Fujita; Takao Ohtsuka; Tomoharu Yoshizumi; Shinichi Aishima; Yoshinao Oda; Hiroshi Honda
Journal:  Eur Radiol       Date:  2016-10-17       Impact factor: 5.315

2.  Left hepatic trisectionectomy for hilar cholangiocarcinoma presenting with an aberrant biliary duct of segment 5: a case report.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Masahiko Komagome; Takashi Ishida; Nobuhiro Shin; Narihiro Cho; Fumiaki Ozawa; Daijo Hashimoto
Journal:  J Med Case Rep       Date:  2010-08-06

3.  The Impact of MDCT and Endoscopic Transpapillary Mapping Biopsy to Predict Longitudinal Spread of Extrahepatic Cholangiocarcinoma.

Authors:  Kyoji Ito; Yoshihiro Sakamoto; Hiroyuki Isayama; Yosuke Nakai; Takeyuki Watadani; Mariko Tanaka; Tetsuo Ushiku; Nobuhisa Akamatsu; Junichi Kaneko; Junichi Arita; Kiyoshi Hasegawa; Norihiro Kokudo
Journal:  J Gastrointest Surg       Date:  2018-05-15       Impact factor: 3.452

Review 4.  Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.

Authors:  F Rassam; E Roos; K P van Lienden; J E van Hooft; H J Klümpen; G van Tienhoven; R J Bennink; M R Engelbrecht; A Schoorlemmer; U H W Beuers; J Verheij; M G Besselink; O R Busch; T M van Gulik
Journal:  Langenbecks Arch Surg       Date:  2018-01-19       Impact factor: 3.445

Review 5.  Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology.

Authors:  Dong Ho Lee; Bohyun Kim; Eun Sun Lee; Hyoung Jung Kim; Ji Hye Min; Jeong Min Lee; Moon Hyung Choi; Nieun Seo; Sang Hyun Choi; Seong Hyun Kim; Seung Soo Lee; Yang Shin Park; Yong Eun Chung
Journal:  Korean J Radiol       Date:  2020-08-28       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.